Navajo County approves participation in multistate opioid settlement with generic manufacturers

The Navajo County Board of Supervisors unanimously approved participation in a multistate settlement with several generic opioid manufacturers following an executive session Sept. 9 to receive legal advice.

The board authorized an executive session under Arizona Revised Statutes 38-431.03(A)(3) to receive legal advice from its attorney regarding proposed settlement agreements with eight manufacturers. After returning to regular session, Mr. Moore summarized the settlement proposal and asked the board for approval.

Mr. Moore said the generic manufacturers involved in the multistate Ohio litigation had reached an agreement and that the terms had been outlined for the board in executive session. "I've outlined the basic terms of what the settlement would be in executive session, and I would ask the board for a motion to approve," Mr. Moore said.

A supervisor moved to approve the settlement participation agreements according to the payout schedule and settlement terms discussed in executive session; another supervisor seconded. The motion passed unanimously by voice vote. The transcript lists the manufacturers discussed as Algobin Inc., Emmanuel Pharmaceuticals Inc., Apex Inc., Hickland Pharmaceuticals USA Inc., Endeavor Inc., Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., and Zayas Pharmaceuticals.

The board authorized legal counsel to execute participation agreements with the listed manufacturers; specific payout amounts and the county’s share of settlement proceeds were discussed in executive session and were not read into the public record during the meeting.